| Azacitidine and venetoclax in previously untreated acute myeloid leukemia CD DiNardo, BA Jonas, V Pullarkat, MJ Thirman, JS Garcia, AH Wei, ... New England Journal of Medicine 383 (7), 617-629, 2020 | 2091 | 2020 |
| Telomerase activity in normal leukocytes and in hematologic malignancies CM Counter, J Gupta, CB Harley, B Leber, S Bacchetti | 1183 | 1995 |
| Mitochondrio‐nuclear translocation of AIF in apoptosis and necrosis E Daugas, SA Susin, N Zamzami, KF Ferri, T Irinopoulou, N Larochette, ... The FASEB Journal 14 (5), 729-739, 2000 | 1079 | 2000 |
| Mechanisms of action of Bcl-2 family proteins A Shamas-Din, J Kale, B Leber, DW Andrews Cold Spring Harbor perspectives in biology 5 (4), a008714, 2013 | 888 | 2013 |
| Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax JF Lovell, LP Billen, S Bindner, A Shamas-Din, C Fradin, B Leber, ... Cell 135 (6), 1074-1084, 2008 | 704 | 2008 |
| Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells E Sachlos, RM Risueño, S Laronde, Z Shapovalova, JH Lee, J Russell, ... Cell 149 (6), 1284-1297, 2012 | 572 | 2012 |
| BH3-only proteins: Orchestrators of apoptosis A Shamas-Din, H Brahmbhatt, B Leber, DW Andrews Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1813 (4), 508-520, 2011 | 519 | 2011 |
| Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator C Brenner, H Cadiou, HLA Vieira, N Zamzami, I Marzo, Z Xie, B Leber, ... Oncogene 19 (3), 329-336, 2000 | 512 | 2000 |
| Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes B Leber, J Lin, DW Andrews Apoptosis 12, 897-911, 2007 | 472 | 2007 |
| Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis MG Annis, EL Soucie, PJ Dlugosz, JA Cruz‐Aguado, LZ Penn, B Leber, ... The EMBO journal 24 (12), 2096-2103, 2005 | 472 | 2005 |
| Bcl‐2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types. W Zhu, A Cowie, GW Wasfy, LZ Penn, B Leber, DW Andrews The EMBO journal 15 (16), 4130-4141, 1996 | 431 | 1996 |
| Bcl-XL inhibits membrane permeabilization by competing with Bax LP Billen, CL Kokoski, JF Lovell, B Leber, DW Andrews PLoS biology 6 (6), e147, 2008 | 385 | 2008 |
| Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia DJ DeAngelo, KE Stevenson, SE Dahlberg, LB Silverman, S Couban, ... Leukemia 29 (3), 526-534, 2015 | 341 | 2015 |
| Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin S Assouline, B Culjkovic, E Cocolakis, C Rousseau, N Beslu, A Amri, ... Blood 114 (2), 257-260, 2009 | 341 | 2009 |
| Bcl‐2 changes conformation to inhibit Bax oligomerization PJ Dlugosz, LP Billen, MG Annis, W Zhu, Z Zhang, J Lin, B Leber, ... The EMBO journal 25 (11), 2287-2296, 2006 | 337 | 2006 |
| Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy CJ Owen, CL Toze, A Koochin, DL Forrest, CA Smith, JM Stevens, ... Blood, The Journal of the American Society of Hematology 112 (12), 4639-4645, 2008 | 287 | 2008 |
| Interaction with a membrane surface triggers a reversible conformational change in Bax normally associated with induction of apoptosis JA Yethon, RF Epand, B Leber, RM Epand, DW Andrews Journal of Biological Chemistry 278 (49), 48935-48941, 2003 | 244 | 2003 |
| Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed MJ Keating, B Cazin, S Coutre, R Birhiray, T Kovacsovics, W Langer, ... Journal of Clinical Oncology 20 (1), 205-213, 2002 | 244 | 2002 |
| Still embedded together binding to membranes regulates Bcl-2 protein interactions B Leber, J Lin, DW Andrews Oncogene 29 (38), 5221-5230, 2010 | 209 | 2010 |
| The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation HA Zahreddine, B Culjkovic-Kraljacic, S Assouline, P Gendron, ... Nature 511 (7507), 90-93, 2014 | 203 | 2014 |
